ADENTRA (ADEN) Q3 2024 earnings summary

Executive summary

• Q3 2024 sales reached $568.8 million, up 1.8% year-over-year, driven by the Woolf acquisition, which contributed $31.4 million and offset a 3.7% decline in organic sales.

• Net income rose 28.7% to $10.4 million, with basic EPS at $0.42.

• Gross margin improved to 21.3%, supported by higher-margin acquisitions, product mix, and strategic initiatives.

• Adjusted EBITDA fell 7.2% year-over-year to $48 million due to increased operating expenses and softer sales.

• Quarterly dividend increased by 7% to C$0.15 per share, effective January 31, 2025, marking the 12th consecutive annual increase.

Financial highlights

• Total sales rose by $10.1 million to $568.8 million compared to Q3 2023.

• US sales grew by $8.4 million to $524.9 million, despite a 3% price and 2% volume decrease; organic US sales fell 4.4%.

• Canadian sales increased by CAD 3.3 million to CAD 59.9 million, with a 10% volume increase and 4% price decrease.

• Gross profit was $121.4 million, up 2.6% year-over-year, with a gross margin of 21.3%.

• Operating expenses decreased by $4.2 million to $96.7 million, mainly due to the non-recurrence of $15.5 million in trade duties.

Outlook and guidance

• Q4 2024 adjusted EBITDA anticipated to align closely with Q4 2023, despite affordability pressures and slow interest rate reductions.

• Expect solid cash flow in Q4 2024, supporting continued debt repayment and further acquisitions.

• Multi-year growth expected, with favorable building market conditions forecasted for H2 2025 and beyond, driven by expected interest rate reductions and strong housing fundamentals.

• Destination 2028 plan targets $800 million in additional run-rate revenue via acquisitions, 10%+ EBITDA margin, and 12%+ ROIC.